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This study was undertaken to assess the efficacy of both fresh and 
preserved xenogeneic amniotic membrane as biologic dressings in reducing 
log bacterial counts of infected burn wounds in comparison with fresh 
allogeneic skin. 
Materials and Methods 
Sixty-four Sprague-Dawley rats (300 gm) were anesthetized and subjected 
to standard 20% BSA dorsal scald burns (Day 0). All wounds were 
immediately surface inoculated with 108 P. aeruginosa from 18 hour broth 
cultures. At Day 5, the 60 survivors underwent escharectomy and random 
biopsies of the sub-eschar wounds. Each wound had bacterial counts >105 
organisms/gm tissue. Animals were then randomized into four treatment 
groups: 1) Control - dry sterile gauze dressing; 2) fresh split 
thickness skin allograft; 3) freshly harvested, sterile human amniotic 
membrane; 4) lyophilized sterile human amniotic membrane (obtained 
fresh, freeze-dried to moisture content of < 0.05%). Before 
application, lyophilized amniotic membrane was reconstituted by 
immersion in buffered Ringer's lactate, pH 7.4. All amniotic membrane 
was applied chorion-side to the wound. All dressings were changed at 
Day 7 (52 survivors) and removed on Day 9 (45 survivors). On Day 7 and 
Day 9, 4 randomized wound biopsies were taken from each animal. 
Results and Conclusions 
Treatments with fresh and preserved xenogeneic amniotic membranes did 
not differ significantly from one another or the control group. Neither 
treatment decreased log bacterial counts. Fresh allogeneic skin 
significantly reduced log bacterial counts at Day 7 (p<0.05) and at Day 
9 (p<0.001). These results are consistant with the absence of any 
intrinsic antibacterial properties of either fresh or preserved amniotic 
membrane. The observation that fresh allogeneic skin is effective in 
reducing bacterial counts in this model, supports the hypothesis that an 
initial attempt at "take" may be reguired for antibacterial efficacy of 
a biologic dressing. 
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Biologic dressings are useful in the treatment of partial and full 
thickness skin loss to functionally replace the skin until such time as 
it can be restored either through regeneration or autografting. 
Material, usually skin, derived from many animal species has been used. 
Currently cadaver and porcine skin are the most popular and are 
commercially available, but at a relatively high cost. Amniotic 
membrane has recently enjoyed new popularity as a biologic dressing as 
is evidenced by numerous clinical reports. It has been postulated that 
fresh amniotic membrane is capable of reducing the quantitative 
bacterial counts both in clinical (human) and experimental (animal) burn 
wounds. This project was designed to further investigate this 
hypothesis and explore the possibility of lyophilization as a method of 
preservation of the amniotic membrane while retaining its antibacterial 
effects. Preservation with retention of antibacterial efficacy would 
allow amniotic membrane to be used in areas where it has been previously 
unavailable. The following review of the literature will summarize the 
use of biologic dressings with emphasis on amniotic membrane, 
concentrating on its recent clinical revival, methods of preservation, 
and investigations bearing on the mechanisms of its antibacterial 
effect. In this discussion the term "amniotic membrane" will refer to 
the placental membranes in the natural state, "amnion" to amniotic 
membrane stripped of chorion, and "chorion to amniotic membrane 
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stripped of amnion. Terms in the older literature such as homograft and 
heterograft, have been replaced with the currently accepted terms 




Biologic dressings may be used to promote healing of partial 
thickness wounds. They are however especially useful and possibly 
lifesaving when re-establishment of permanent skin continuity by 
autografting is temporarily prevented because donor sites are lacking, 
the patient is too ill to withstand the graft harvesting procedure, or 
the recipient site is not yet ready. In this case the biologic 
dressings have the capacity to 1) temporize - allowing multiple same- 
site harvesting of split-thickness skin graft or improvement in the 
general status of the patient and 2) prepare the recipient site for 
grafting. Adequate supplies are available because allograft and 
xenograft material may be used.1-5 Permanent "take" of the biologic 
dressing is not desirable and is prevented by frequent dressing changes, 
that is, every 48-72 hours or more often if treatment of infection is 
also required. Prevention of "take" by dressing changes avoids the 
morbidity of a debilitating rejection episode. The frequent changes 
encourage debridement of necrotic or infected tissue. 
It has been demonstrated that for consistent autograft survival 
quantitative bacterial counts in the recipient bed must be less than 105 
/gram of tissue.6 Thus the ability of biologic dressings to reduce or 
prevent infections has been of great interest. This will be discussed 
in more detail below. 
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The early history of biologic dressings, as well as the advantages 
and disadvantages of their use, has been well summarized 7-8 and will 
not be discussed here. It should be noted that much effort has been 
expended to develop a synthetic material with characteristics such as 
adhesiveness, porosity, and bacteriostasis, reguired for an artificial 
skin, with limited success.9'14 
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B. Amniotic Membrane 
The use of amniotic membrane as a graft was apparently first 
suggested by Thornton, at the time a senior medical student at Johns 
Hopkins Hospital, and reported by John Davis in 1910 in his monumental 
review of skin transplantation at the same institution.15 Not specifying 
any of the technical details of his experiments, Davis notes that the 
grafts were not successful but suggests that the "material is well worth 
a trial." Early investigators believed that this human embryonic 
material was less likely to be rejected than animal skin and would 
provide the necessary ingredients for regenerating skin, being derived 
from ectoderm and being an "extention of the fetal skin."16 
In 1913 Sabella16 and Stern17 published independent reports of their 
successful use of amnion in the treatment of "burns, scalds, varicose 
ulcers, and denudations of traumatic origin." It is apparent that they 
believed there was actual take and incorporation of the fetal cells into 
the new skin. Stern notes that a major advantage in the use of amniotic 
membrane is the avoidance of anesthesia and the second wound neccessary 
at the donor site for autografts, a point which is still important 
today. 
Amniotic membrane then became popular for a time in neurologic and 
opthalmologic surgery, but further discussion of its use is generally 
absent from the plastic surgery literature until the end of World War 
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II, which generated large numbers of burn casualties and the spectre of 
thermonuclear war. Papers published in the early 1950's discuss the 
neccessity of developing and stockpiling substitutes for homograft skin, 
the supplies of which would be quickly exhausted by an atomic war.18 
The next stage in the development of use of amniotic membrane was 
marked by independent reports of its clinical use in a variety of 
situations. Workers described unique methods of preparation or 
postulated mechanisms for its unusual properties. Unfortunately there 
is much confusion of terms, lack of precision in description of methods 
used, and most clinical and experimental reports are of a subjective, 
qualitative nature. An attempt will be made to summarize those findings 
which are relevent to the current understanding of the role of amniotic 
membrane, and its limitations. 
Troensgaard-Hansen used boiled amnion, placing the epithelial surface 
against the wound, as a graft in the treatment of chronic skin ulcers in 
elderly bed-ridden patients and reported complete healing.19 He 
recommended 10 weeks of bed rest during v/hich the dressing was not 
disturbed. A student of his, Kidd, dried the boiled amnion over cotton 
wool balls and took a supply with him on an Arctic cruise.20 After 7 
months of storage the amnion was rehydrated by boiling in saline and 
used to cover a 6 cm2 full thickness wound. Kidd states that at the 
7-day dressing change the wound was completely re-epithelialized. 
Sterling reported his use of amniotic membrane in the pre-autograft 
treatment of debrided human flame wounds.21 Van Duyn emphasized the 
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importance of an appropriately timed escharectomy in the treatment of 
third degree burns even if permanent skin coverage was not yet 
available.22 He recommended use of amniotic membrane to prevent the loss 
of protein, fluid and electrolytes from open, weeping, granulation 
tissue, while awaiting autograft skin. 
Dino et al. were impressed with the utility of amnion in the 
treatment of second degree burns and split-thickness skin graft donor 
sites.23 They emphasized the rapid relief of pain after the application 
of the dressing. Histologic study of biopsies of these donor sites 
failed to show vascularization of the amnion. The membrane was, 
however, "richly invaded with phagocytic cells." Dino and coworkers 
later established an amnion bank, after demonstrating that bacterial 
growth was prevented when amnion was stored in solutions of sodium 
hypochlorite, saline with penicillin and streptomycin, or saline with 
kanamycin at 5°C or up to 14 days.24 Pigeon stored amnion in antibiotic 
solution for up to nine months and used this this amnion to successfully 
treat second degree burns.25 He felt that the viability of the tissue 
was not a prerequisite for good outcome, recognizing there was no 
evidence that the amnion cells reproduced on the skin. 
Trelford et al. used allogeneic amnion (amniotic membranes stripped 
of chorion) as a dressing on the perineum following radical vulvectomy 
by suturing it into lace mesenchymal-side place mesenchymal side-down 
(amnion epithelium up). They stated that unpublished preliminary 
studies indicated a lack of "cellular immunologic response" when the 
amnion was used in this manner. They attributed their successful 
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clinical results to prevention of this reponse which was accomplished by 
1) avoidance of the "antigenic chorion" and 2) application of the 
mesenchymal side to the wound. In their unpublished pilot studies 
application of the amnion mesenchymal-side down did not lead to 
capillary and cellular invasion of the amnion in a xenogeneic 
model.2 6-2 8 
Douglas demonstrated histologic survival of fresh xenogeneic amnion 
or chorion when grafted onto experimental dog wounds. However she 
followed the wounds for only 17 days.29 In light of this she treated a 
burn wound with amnion allograft and two split thickness skin graft 
donor sites with chorion allograft and again demonstrated histologic 
survival of the cells of both membranes for about three weeks. 
Later Douglas et al. using the transparent tissue chamber technique, 
studied the behavior of human amnion grafted onto full thickness mouse 
wounds.30 They first noted thrombosis of vessels in the recipient bed, 
followed by neovascularization of this bed. At no time was penetration 
of the chorion graft by the neovascular process observed. However, the 
graft remained viable for an average of 12 days as compared to an 
average viability of 5.6 days for an allograft skin control (thickness 
not specified). Douglas et al. also studied amniotic membrane 
autografts in the same model. Significantly they demonstrated no 
recipient bed vessel thrombosis. Rapid re-epithelialization of the 
wound surface by cells originating from the wound edges occured. 
Whether these cells were of dermal or placental origin is not clear. 
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Colocho et al. studied the question of neovascularization of 
amnion.31 Both fresh and viable-preserved (frozen in 20% glycerin; 
viability asesed post-thaw by eosin excusion) amnion were used in 
clinical (65 split thickness skin graft donor sites and 42 partial 
thickness burns) and experimental (applied to open wound on the rat 
panniculus carnosis or buried subcutaneously) models. Careful studies 
demonstrated the absence of any vascular connections between amnion 
graft and any of the beds in both clinical studies (allogeneic) and 
experimental models (xenogeneic). 
More recently the results of large clinical trials of amniotic 
membrane have been reported; most have been anecdotal. Chuntrasakul 
described his subjective experience with 265 patiets, including 215 burn 
patients, using fresh allogeneic amniotic membrane.32 140 of the 
patients had "minor" burns - mostly partial thickness, 2-15% BSA - and 
were treated by 1-3 applications of amniotic membrane amnion-side down. 
Eighty per cent remained free of infection by clinical signs and none 
required hospitalization. Seventy-five of the burns were classified as 
"major" - mostly full thickness, 13-75% BSA. These wounds were treated 
by application of the amniotic membrane chorion-side down after 
escharectomy ( dressings changed every 48 hours). The membranes were 
reported to have decreased fluid, electrolyte, and protein loss, and 
increased vascularity of the granulating wound. However, no data was 
provided. Eldad and coworkers reported a series of 30 patients (15 
burns) in whom allogeneic amniotic membrane was used.33 In partial 
thickness skin loss the amnion side was applied to the wound while in 
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full thickness loss the chorion side was applied against the wound with 
the specific aim of enhancing granulation tissue formation on denuded 
areas as a prelude to skin graft application. Walker, Cooney, and Allen 
compared fresh allogeneic amnion to Furacin impregnated gauze in 110 
children presenting with second and third degree burns.34 In the 58 
patients requiring hospitalization because of size, depth, or location 
of wound, they demonstrated that those treated with amnion (18, av burn 
13% BSA) required hospitalization periods of significantly shorter 
duration (16 vs 27 days) than those treated with the Furacin gauze (40, 
av burn 12% BSA). However the time required for healing was not 
significantly different. Bose has reported in detail his management 
protocol for burn wounds where depth of injury is not known or is 
variable, using fresh allogeneic amniotic membrane in 15 patients.35 
Thompson and Parks reported storage of human amniotic membrane in 10% 
glycerol at -80 C for periods as long as 300 days.36 The material was 
then used as a biologic dressing in the interim management of pediatric 
burn wounds. Best results were seen when the membrane was used as a 
cover dressing over meshed skin autograft on fascial surfaces. Rapid 
closure of the graft interstices with graft loss of less than 5%, was 
observed. 
Finally Gruss and Jirsch used fresh allogenic amniotic membrane 
applied chorion-side down in 120 patients with full thickness defects, 
including ulcers, elective, infected or contaminated surgical wounds, 
saucerized bone, burns, and traumatic soft tissue wounds.37 Twenty-three 
of these v/ounds were clinically infected. The membranes were used to 
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reduce the log bacterial count. "Take" of the membranes was used as a 
clinical indicator of reduction of bacterial counts to below 105 
bacteria/gram of tissue. They defined "take" clinically, i.e. when firm 
adherance of the membrane to the wound bed without underlying 
accumulation of pus or debris was observed. When "take" was evident, 
delayed wound closure was accomplished. Gruss and Jirsch concluded that 
the "take" of human (allogeneic) amniotic membrane applied to the wound 
surface was invariably a good predictive index of successful autograft 
take or wound closure. 
Many clinicians have observed and reported alterations in wound 
healing - rapid re-epithelialization, enhanced granulation tissue 
formation, relief of pain - when amnion or amniotic membrane is used as 
a wound dressing. Recent studies have attempted to elucidate the 
mechanism(s) whereby amnion exerts these reported beneficial effects. 
One such effect is an apparent acceleration of wound healing. Rabat and 
Kothary studied, by the transparent chamber technique, rabbit amnion 
grafted onto an excisional wound on a rabbit ear, over a 20 day 
course.38 Membranes were collected by Ceasarian section, maintained in 
Eagles MEM with added antibiotics, and were used within 10 days. They 
observed an earlier appearance and faster progression of granulation 
tissue as compared to their wound controls. In addition, grafted wounds 
were characterized by a greater degree of fibroblast and epithelial cell 
migration, increased collagen synthesis, and more rapid growth of a 
well-formed epithelial layer. However gross observation revealed no 
difference between the grafted and the control wounds. Specifically, 
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there was no enhancement of wound angiogenisis by the amnion grafts. 
Based on these observations, Babat and Kothary concluded that wound 
healing was accelerated in the presence of allogeneic amnion grafts. 
They speculated that a mechanism existed whereby living amnion promoted 
"tissue differentiation." It should be noted that in this study amnion 
was maintained in tissue culture medium prior to use, and this method of 
storage may have affected its properties. Additionally, rabbits were 
treated with immunosuppressive doses of cortisone acetate - doses known 
to affect wound healing.39 Importantly, in this allograft model, there 
was no evidence for vascular penetration of the amnion by the host bed. 
In contrast to the experimental study above demonstrating no apparent 
effect of amnion on angiogenisis, Faulk and co-workers reported clinical 
trials with amnion in which they suggest it is endowed with "angiogenic 
factors" similar to the vessel growth promoting factors said to be 
produced by tumor cells. Faulk et al. using histologic and 
immunohistologic techniques (antiserum to Factor VIII as a marker of 
endothelial cells) studied 15 human chronic leg ulcers via biopsies 
taken prior to and 5 days after application of human amnion dressings. 
In these experiments human amniotic membrane was maintained in culture 
for up to three weeks; chorion was stripped off immediately before 
application. H & E, reticulin, and immunoflourescent stains 
demonstrated an increase in the number of capillaries in the ulcer bed, 
along v/ith increased patency of vesseels, thinned connective tissue, and 
increased numbers and brilliance of the immunoflourescent granules. 
Thus, in this allogeneic model there was evidence of increased 
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vascularity after exposure to amnion.40-41 
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C. PRESERVATION OF AMNIOTIC MEMBRANE 
One of the attractive features of amniotic membrane as a biologic 
dressing is its ready availability in great quantities, especially in 
the large hospitals where it is likely to be needed. However widespread 
use of amniotic membrane has been limited by the high manpower costs of 
preparation and the difficulties encountered in storage of fresh, 
sterile material. Many investigators have attempted to solve the 
problem of storage. Basically their solutions can be divided into two 
classes - those which maintain viabiity of the amniotic membrane and 
those which do not. Methods of preparation have included serial washes 
in physiologic solutions,41 immersion and storage in various 
bactericidal agents," storage at low temperature,34 freezing,31 
drying,20 boiling,18 and storage in tissue culture.Some of these 
techniques have been discussed above. One question which has never been 
answered, however, is the question of whether amniotic membrane must be 
living for it to be used successfully as a biologic dressing. 
Rao and Chandrasekharem recently suggested a possible solution to the 
twin problems of preservation and provision of adequate supplies by 
exploring the use of dried bovine amnion.43 They air-dried both human 
and bovine amnion after removing surface contaminents with a dilute 
hypochlorite rinse. The dried amnion was then sealed in envelopes and 
radiation sterilized. The dried amnion (human or bovine) was stored for 
up to nine months before use. Safety, durability, bacteriostatic 
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activity, effectiveness, and adherence of the dried sterile bovine 
amnion was first evaluated in a xenogeneic (rabbit) burn wound model. 
Results were reported as "satisfactory" but noted specifically were 
sterile bacterial cultures from the amnion treated wound area while 
bacterial cultures from the control area were positive for 
Staphylococcus and Pseudomonas. A clinical trial in 70 patients (58 
burns)was then undertaken. Of the 50 burn patients for which 
information is available, 43 (86%) had burns of less than 30% BSA. 
Twenty-seven (62%) of these were superficial burns. In the clinical 
study both fresh and dried allogeneic (human) amnion were compared v/ith 
dried xenogeneic (bovine) amnion. The amnion was applied over both 
superficial and deep burns after minimal debridement immediately after 
admission. In the treatment of deep burns amnion was reapplied post- 
escharectomy and when there were signs of infection or autolysis of the 
amnion. The authors state that there were no differences between the 
various types of amnion used. However, how this was established is not 
evident from the paper; only subjective observations were reported. 
Preservation of skin (human or porcine) by lyophilization (freeze¬ 
drying) for use as a temporary biologic dressing is a common 
practice.44"45 It is important to note that the lyophilization process 
does not preserve tissue viability and therefore permanent "take" is 
precluded. Only two studies could be found in the literature in which 
lyophilization was used to preserve amniotic membranes. In the first 
study, Klen described a rather complicated and time consuming method 
used at the Tissue Bank Faculty Hospital in the CSSR.46"47 Strips of 
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amnion, chorion, or amniotic membrane, were placed on a plastic net, 
rolled, and stored under a nitrogen atmosphere in a "deep freeze" prior 
to lyophilization. Materials were then lyophilized for a period of 48 
hours. Dry sterile nitrogen was then admitted to the jars and they were 
sealed. The lyophilized membrane was arbitrarily assigned a shelf life 
of one year. Rehydration was accomplished of the membrane for 10 
minutes in sterile water (not physiologic solution) containing 
antibiotics and calcium gluconate. Klen stated that membranes prepared 
within two hours of delivery and stored for less than one week before 
lyophilization provided the more "successful" grafts. 
In a procedure described more recently by Notea et al., amniotic 
membrane v/as spread on gauze covered tray and frozen at -20 °C.48 The 
frozen amniotic membrane was lyophilized for 24 hours, and placed in 
polyethylene sacks, and sterilized with ethylene oxide. Amniotic 
membranes prepared in this manner were stored at room temperature. They 
were rehydrated by immersion in physiologic saline solution. The 
authors used reconstituted amniotic membranes in six cases of various 
full thickness skin injuries. They concluded that the freeze-dried 
amniotic membrane compared favorably with fresh amniotic membrane with 
respect to its effects (adherence, enhanced epithelialization, healing 
time) on the wound bed. However their report did not document this by 
any objective criteria. 
The studies of Klen and Notea constitute the only reported 
investigation of the use of a lyophilized amniotic membrane as a 
biologic dressing in either allogeneic or xenogeneic wounds. No studies 
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detailing the antibacterial efficacy of lyophilized amniotic membrane as 
compared to fresh material have been reported to date. 
Recently, it has been shown that lyophilization of bone, skin and 
certain cultured cells changes the cell surface lipoprotein 
histocompatibility antigens, rendering cells and tissues only weakly 
stimulating of cellular immunity after transplantation in allogeneic 
models.49 while this observation has been confined to tissues other than 
amniotic membrane, there is no reason to suspect that amniotic membrane 
would behave any differently. Thus, if the antibacterial properties of 
the membrane are preserved after lyophilization, a concommitant decrease 
in antigenic potential could only be to the benefit of the alio- or 
xenogeneic wound in which it might be used. 
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D. ANTIBACTERIAL PROPERTIES OF AMNIOTIC MEMBRANE 
Eade noted in 1958 that despite the presence of bacteria in 
granulation tissue, split thickness autografts took well.50 He theorized 
that this occured because of a rapid removal of bacteria. In his 
clinical experiments, he observed that a reduction in quantitative 
bacterial levels occured by 24 hours post-grafting in most patients 
undergoing either autografting or allografting of either fresh or 
lyophilized skin. 
Since that time the ability of either autograft or allograft skin to 
reduce wound bacterial levels has been repeatedly confirmed. In fact, 
the ability to decrease bacterial levels is considered an important 
criterion in the selection of a biologic dressing. Biologic dressings 
endowed with this property can be used both therapeutically to "clean¬ 
up" wounds prior to grafting and prophylactically to suppress bacterial 
overgrowth in wounds which for other reasons cannot be grafted. 
Robson and Krizek undertook a quantitative study of the antibacterial 
efficacy of amniotic membrane in an infected xenogeneic wound model.51 
Their reported results have become a standard for comparison, and it is 
therefore important to review their study in detail. The animal was a 
250 gram Sprague-Dawley rat subjected to a 20% full thickness scald 
burn. Immediately after burning, the burned areas were topically 
inoculated with IxlO8 Pseudomonas aeruginosa from an 18 hour broth 
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culture. Animals surviving at Day 5 post-burn (33/50) underwent 
escharectomy. Bacterial infection was confirmed by quantitative tissue 
cultures on the day of escharectomy. Each wound was divided into three 
equal segments along the rostral caudal axis. To each segment of each 
animal was applied one of three dressings: fresh human amniotic 
membrane, split thickness human skin, dry sterile gauze dressing 
(control). Wound biopsies for quantitative log bacterial counts were 
performed at 48 hours post-escharectomy, at which time appropriate fresh 
dressing were applied. Biopsies were repeated at 96 hours post- 
escharectomy. Results at 96 hours post-escharectomy were reported to be 
most significant. The authors reported a reduction in log bacterial 
counts in 100% of the amniotic membrane treated wounds, 90% of skin- 
grafted wounds, but in only 40% of control wounds. Of the remaining 
control wounds, 2/3 showed no change in bacterial count while 1/3 
exhibited increased log bacterial counts. The geometric mean of the 
bacterial counts from the group treated with human split thickness skin 
was 106 bacteria/gram, compared to 103 bacteria/gram in the group 
treated with amniotic membrane. While the authors report signifigance 
of p values, they fail to report the number of surviving animals in any 
group at any time post-escharectomy, i.e. from Day 5 when the first 
dressings were applied to the termination of the study on Day 9. 
Additionally they do not report what they considered to be a 
"significant reduction" in bacterial count. 
Robson and Krizek next studied the question of whether human amniotic 
membrane or human skin exhibited any intrinsic antibacterial properties 
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in vitro. 53 To an inoculum of 103 to 108 P. aeruginosa or E. coli in 
an unreported volume of thioglycolate medium, was added 50-200 mg of 
either homogenized human skin or homogenized human amniotic membrane. 
Within 24 hours after addition, all cultures exhibited counts of 108 
bacteria/ml. 
Based on these experiments the authors concluded that neither human 
amniotic membrane nor human skin posess inherent bactericidal or 
bacterostatic properties. The study is subject to criticism, however in 
that the methodology chosen really is not adequate to discern any 
postulated intrinsic antibacterial factors. Furthermore the 
concentrations of the initial inoculum and the homogenate are not 
reported, and the results are difficult, if not impossible to interpret. 
There is ample evidence to suggest that these factors may affect the 
growth curve rather than the final concentration of bacteria. Early and 
serial sampling should be done to detect this. 
Later, Robson et al. developed a model to study the effect of 
dressings on the growth of bacteria, hypothesizing that a low initial 
inoculum would more closely simulate the clinical situation of an 
infected granulating wound bed.52 Four full thickness defects (1.5 cm2 ) 
were made on the backs of each of 20 rats. Each defect was immediately 
innoculated with 5xl05 P. aeruginosa and covered with one of 5 
dressings: split thickness autograft skin, split thickness allograft 
skin, split thickness xenograft porcine skin, split thickness xenograft 
human skin, or fresh xenogeneic human amniotic membrane. At the end of 
48-72 hours, quantitative tissue biopsies revealed 106 bacteria/gram in 
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the allograft and xenograft skin treated wound beds as compared with 103 
bacteria/gram in the xenogeneic amniotic membrane or autograft skin 
treated wounds. The authors concluded that amniotic membranes were 
superior to allograft and xenograft skin in decreasing wound bacterial 
counts. This second model is also open to criticism, as they presented 
no evidence that equivalent infection levels were achieved beneath the 
dressings, which were applied immediately after wound innoculation. The 
dressings may have affected the bacteria before their invasion of the 
wound bed. Thus, their experimental model does not simulate the 
clinical use of the dressings. 
Although these studies have become the standard of reference with 
respect to the antibacterial efficacy of amniotic membrane as compared 
with other biologic dressings, critical experimental details were 
unfortunately omitted by the authors: the description of burning is too 
sketchy and refers the reader to other works which are no more helpful, 
the same strain of Pseudomonas was not used throughout any series of 
studies, authors failed to note whether amniotic membrane was applied 
amnion-side down or chorion side down. Probably most importantly, the 
authors utilized 3 different dressings in one wound. The small areas 
involved and failure to isolate one from another produce cross¬ 
contamination and sampling errors which raise serious doubt as to the 
validity of the quantitative bacterial counts. Finally, as noted 
earlier information presented in the studies is incomplete and thereby 
does not permit proper statistical analysis. 
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Walker, Cooney and Allen demonstrated in a clinical trial that amnion 
was better than Furacin gauze in limiting the number of positive 
bacterial surface cultures of several common pathogens (cultured during 
dressing change).34 Indeed, in their trial 18% of burn wounds 
demonstrated repeated sterile cultures as compared with 100% 
contamination of the Furacin treated wounds. 
Salisbury et al. have compared the bacterial clearing effects of 
amnion (actual membrane not specified), homograft skin and porcine 
xenograft in a clinical trial of second and third degree burn v/ounds in 
16 patients.53 Most v/ounds exhibited no change in the log bacterial 
count at 24 hours. However they limited use of the biologic dressings 
to those v/ounds judged clinically not to be ready for grafting and 
evaluated the v/ounds only once, 24 hours after application of the 
dressing. In addition, the origin and preparation of the "amnion" and 
the type of allograft used is not specified, making this study difficult 
to interpret. 
Many authors have postulated mechanisms for the apparent 
antibacterial effects of amniotic membrane.54 Those who subscribe to the 
mechanical theory assert that the amniotic membrane achieves an intimate 
biologic closure of the v/ound through f ibrin-elastin bonding, 
encouraging a functional circulation in the granulation tissue thereby 
increasing the turnover of leukocytes. Additionally, changing the 
membrane frequently serves to debride devitilized tissue. Those 
adhering to the biochemical theory claim that amniotic membrane is 
endowed with intrinsic antibacterial factors. The existence of 
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bactericidal and bacterostatic systems in amniotic fluid has been well 
documented in vitro. 55-63 whether these factors are produced by the 
amniotic membrane and/or are retained after delivery in sufficient 
quantities to affect wound bacteriology is not known. A third theory, 
of "take", combines elements Of the biochemical and mechanical theories. 
Some experimentors hypothesize that "take" of the amniotic membrane is 
required for antibacterial efficacy. This is usually intended to mean 
the establishment of a biologic interconnection of the graft and the 
wound bed by vascular invasion of the amniotic membrane. This is 
achieved only when the rejection mechanisms are attenuated either 
because of suppression or allogeneity of the graft. Vascular invasion 
with active blood flow would achieve beneficial effects by well known 
mechanisms, as well as distributing the postulated intrinsic 
antibacterial factors of amniotic membrane. 
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E. STUDY DESIGN 
To summarize, recent clinical and experimental investigations have 
clarified details of the use of allogeneic amniotic membrane in the 
treatment of skin wounds.64 Partial thickness losses are treated by 
application of the amniotic membrane with the epithelial amnion side in 
contact with the wound. This discourages vascular penetration and is 
reported to encourage epithelialization. When applied in this fashion, 
the amniotic membrane is removed only if there is evidence of infection 
beneath it. Otherwise healing progresses to completion under cover of 
the dessicating membrane which falls away after epithelilization is 
complete. Full thickness losses are treated by debridement of necrotic 
tissue followed by application of the amniotic membrane chorion-side 
down. This can be done even in the face of residual v/ound infection, 
providing that the amniotic membrane is changed freguently. Apparent 
"take" of the amniotic membrane to the wound bed as judged by its 
adherence to same is a good indicator of low bacterial counts in the 
v/ound. A biologic dressing probably should not be used in areas of 
variable depth of injury v/ith potential for infection in order to 
prevent conversion of the entire wound to a full thickness loss.65 
Although sufficient clinical experience has been accumulated to 
permit use of amniotic membrane as detailed above, there remain large 
gaps in our knowledge. Are there intrinsic factors in amniotic membrane 
which affect v/ound healing and v/ound flora? Must there be vascular 
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ingrowth for the amniotic membrane to function effectively as a biologic 
dressing over full thickness defects, i.e. must there be a "take" ? 
Must the amniotic membrane be viable (consist of living cells) to exert 
its beneficial effects? Finally, how does the heterogeneity of the 
biologic dressing affect its ability to function? 
The goal of this project is to further investigate the antibacterial 
effects of amniotic membrane and to explore the possibility of using 
lyophilization as a method of preservation of the membranes. If the 
non-viable lyophilized amniotic membrane functions as effectively as the 
viable fresh amniotic membrane it would imply that the beneficial 
properties are independent of viability dependent mechanisms such as 
vascular ingrowth, and support the mechanical or biochemical theories. 
The parameter chosen for study was the effect of the biologic dressing 
on quantitative wound bacteriology. Quantitative tissue bacterial 
counts are simple to perform, reproducible, reliable, and represent a 
parameter by which clinicians judge the success of a biologic dressing. 
Because the work of Robson and Krizek has become a standard of 
reference, frequently cited as demonstrating antibacterial efficacy of 
amniotic membrane, it was considered important to replicate their 
xenograft septic burn wound model. Their original design used three 
dressings on a single wound.51 As discussed above this does not allow 
clear separation of the individual dressing's effects. Therefore in 
this project only one dressing type was used for each wound. 
The experimental design was therefore as follows: Rats received a 
standard 20% dorsal scald burn66-68 which was immediately surface 
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inoculated with a pathogenic strain of P. aeruginosa.69-71 On Day 5 
post-burn, escharectomy was performed and quantitative bacterial tissue 
counts were done to establish wound bed infection. Rats were randomized 
into four groups, receiving fresh xenogeneic human amniotic membrane, 
lyophilized xenogeneic (human) amniotic membrane, fresh allogeneic full 
thickness skin, or plain sterile gauze. The latter two were considered 
controls. On Day 7 the dressings were removed and biopsies for 
quantitative tissue bacterial counts were taken. Appropriate new 
dressings were applied. On Day 9 the dressings were removed, biopsies 
taken and the rats were sacrificed. Logistical problems prevented 
accomplishment of certain procedures at one time so that the experiment 




MATERIALS AND METHODS 
A. Animals 
Male albino Sprague-Dawley rats (av wt 312 gms) were acclimatized for 
1-2 weeks, housed in groups of 10 at the Animal Care Facility, Yale 
School of Medicine. After burning, rats were placed in individual wire 
screen "drop-through" cages to minimize cross-contamination and 
innoculation of the wound by fecal flora, and kept in the Plastic 
Surgery Laboratory. Rat chow and water were available ad libitum. 
B. BACTERIA 
A pathogenic strain of Pseudomonas aeruginosa was obtained from the 
clinical bacteriology laboratories of Yale-New Haven Hospital. This 
isolate (YNHH-9621-1981) was used to inoculate a trypticase soy broth 
culture. During log phase of growth, samples were taken and stored in 
5% glycerin at -70°C for future use. Before each experiment one of 
these samples was used to inoculate a new TSB culture. 
C. PREPARATION for BURN 
Rats were anesthetized for burn and escharectomy using sodium 
pentobarbital, 30 mg/kg IP as an initial dose, supplemented by 10 mg/kg 
IP when neccessary. During dressing change and wound biopsy, 10 mg/kg 
IP sodium pentobarbital was sufficient for sedation. 
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Weight of rats was recorded. The entire dorsum of the body was then 
closely shaved using a mechanical clippers. 
D. BURN 
Rats were subjected to a 20% BSA standard dorsal scald burn using a 
simple device. A sheet of Plexi-glass (14x28cm) with a window (5x8cm) 
was used to cover a stainless steel pan (5x12x22cm) filled with water. 
The pan was set on a metal stand and the water heated to 75 °C using a 
Bunsen burner. The shaved dorsum of the rat was placed against the 
window for 20 seconds. Literature review and preliminary studies 
indicated that this scald (75°C, 20 secs) caused a full thickness 
injury. The body surface area of the rat was calculated using the 
formula BSA=kW2/3 , where W is the weight in grams and k is a constant 
(empirically determined to be 11).72 The window size chosen represents 
20% of the body surface of a rat of the average weight. 
E. BACTERIAL INNOCULATION 
After burning the dorsum of the rat was immediately dried using 
sterile gauze. After several minutes were allowed to pass for cooling 
of the burned skin, the surface of the scald was inoculated with P. 
aeruginosa (1ml of 18hr broth culture) by swabbing. The broth culture 
was backplated at the time of inoculation to demonstrate a bacterial 




On Day 5 post-burn the eschar was sharply dissected away. Care was 
taken to leave the underlying panniculus carnosis. Dimensions of the 
eschar were measured and recorded for each animal before escharectomy. 
G. QUANTITATIVE CULTURES 
Four random wound bed tissue samples (one from each of the four 
quadrants) were taken immediately from each rat after escharectomy on 
Day 5, during the dresssing change on Day 7, and before the rat v/as 
sacraficed on Day 9. These four samples were pooled and used to define 
quantitative bacterial tissue counts for each rat according to a method 
previously described and in clinical use at Yale-New Haven 
Hospital.73 * 7 4 
H. TREATMENT PROTOCOL 
After escharectomy the rats were randomly assigned to one of three 
wound treatment groups. Treatments consisted of dressings of 1) fresh 
human amniotic membrane, 2) lyophilized human amniotic membrane, 3) 
fresh full thickness allogeneic rat skin. A control group received 
wound dressings consisting of dry sterile gauze. The dressings were 
applied as described belov; immediately after biopsy samples were 
obtained on Day 5 (after escharectomy),and on Day 7 (after removal of 
the old dressing). 
I. DRESSINGS 
1) Amniotic Membrane 
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Amniotic membrane was aseptically collected by the nursing staff of 
the Yale-New Haven Hospital Obstetrical Division at delivery from 
mothers who fit previously established criteria. The membranes were 
stored individually in sterile containers at 4°C and transferred to the 
Plastic Surgery Laboratory within 24 hours. Any membranes with obvious 
meconium staining or foul odor we re discarded. Healthy appearing 
membranes were individually washed under sterile conditions using 5 
rinses of 500 ml each of sterile saline. The third rinse contained 
0.025% sodium hypochlorite. During rinsing, the membranes were gently 
agitated by hand to dislodge adherent blood clots. Care was taken not 
to strip the amnion from the chorion. Biopsies of all membranes were 
subjected to aerobic bacteriologic cultures (blood and MacConkey agar). 
The membranes were returned to cold storage in individual sterile 
containers which were labelled by date of collection. If the 
bacteriologic cultures were without growth at 36 hours, membranes were 
considered sterile and fit for lyophilization or fresh use, otherwise 
the membranes were discarded. Fresh amniotic membrane was recultured 2 
days before it was to be used, and it was discarded if the cultures were 
positive. Fresh membranes were not used longer than two weeks after 
collection in any case. 
2) Lyophilized Amniotic Membrane 
a) Lyophilization 
Amniotic membranes prepared as described above, were spread amnion- 
side down on a backing of Owens Gauze (non-adherent, sterile, surgical 

32 
dressing, Davis and Geek) and cut into sections of 6x10 cm. The gauze- 
backed membranes were then rolled loosely, placed along the inner wall 
of sterile glass jars, and shell-frozen by immersion of the jars into a 
mixture of dry ice and methanol (- 78 °C) for a 10 minute period. 
Lyophilization was accomplished using the Flexi-Dry apparutus (FTS 
SYSTEMS INC.) at final pressures of less than 75 millitorr and at a 
temperature of -50°C. Lyophilization was continued for 24 hours. After 
lyophilization, the freeze-dried membrane was aseptically removed from 
the jars and placed in sterile polyethylene bags, which were tightly 
closed, dated,and stored a 4°C. 
b) Reconstitution of Lyophilized Membranes 
Freeze-dried amniotic membranes were reconstituted immediately before 
use by a 10 minute immersion in lactated Ringer's solution buffered to 
pH 7.4 with sodium bicarbonate (1lmeq/500ml). To facilitate handling 
the membrane was not separated from the gauze backing. 
3) Skin Grafts 
Allograft skin was prepared within 24 hours of use by the method of 
Woodruff and Simpson,75 using 300gm male Sprague-Dawley rats. The 
method consists essentially of closely shaving the rat, raising a small 
flap in the skin, and establishing a plane between the deep dermis and 
the panniculus carnosis. This is most successful if initiated dorsally 
where the panniculus is thickest. Blunt dissection along this plane 
enables one to free up the graft, which is then placed in sterile 
saline-soaked gauze and refrigerated at 4°C. The skin of the entire 
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body can usually be harvested in one piece. 
J. APPLICATION of DRESSINGS 
Dressings were trimmed to size, applied to the wound bed, and covered 
by a dry sterile gauze wrap. Amniotic membrane, fresh and lyophilized, 
was applied chorion-side down. Skin graft was applied in its natural 
orientation. A control group received the sterile gauze dressing only. 




Experimental results are shown in Tables 1-4. Animals which 
succumbed before Day 5 (a total of 9 ) are not included in the table. 
Animals which survived through Day 5 and which were randomized into 
treatment groups are included in the tables even if they succumbed 
before biopsies for quantitative tissue counts were performed. The 
letter "d" indicates death of the animal before biopsy. 
Statistical analysis of the two experimental blocks demonstrated that 
there was no significant difference between them. The effects of 
weight, area of eschar, level of infection at Day 5 on the infection 
level at Day 7 and Day 9 were shown to be independent (p=0.32 and p=0.12 
respectively) of the experimental block. The study blocks therefore 
were pooled to increase the probability of detecting differences among 
the treatment groups. 
Quantitative culture of the wound beds in most cases demonstrated 
presence of other bacteria in addition to Pseudomonas. These bacteria 
(Staphylococcus, Streptococcus, Proteus) are normal rat skin flora. 
Quantitative measurements of these bacteria were recorded. Levels were 
usually 2-3 (log) orders of magnitude lower than the Pseudomonas. 
Analysis of the data using total bacterial counts yielded results nearly 
identical to those obtained when the data for Pseudomonas alone were 
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utilized. For simplicity the data on these resident flora are 




TABLE 1 FRESH AMNIOTIC MEMBRANE 
Bacterial Counts (log base 10) 
group 1 
group 2 
Rat Day 5 Day 7 Day 9 
6 7.05 d d 
8 7.30 d d 
12 6.70 7.18 7.48 
17 6.00 7.48 7.00 
20 6.78 7.63 7.30 
29 6.00 8.30 9.85 
2 5.48 6.95 8.70 
3 6.00 8.48 9.60 
11 6.70 7.30 7.30 
6 7.00 6.85 7.70 
11 6.48 8.30 d 
13 6.00 7.78 7.30 
14 7.30 8.00 7.48 
18 6.00 6.90 8.43 
22 6.00 8.00 7.00 
23 7.30 d d 




TABLE 2 LYOPHILIZED AMNIOTIC MEMBRANE 
Bacterial Counts (log base 10) 
rat Day 5 Day 7 Day 
1 7.73 d d 
3 6.60 9.00 d 
7 6.60 7.00 7.30 
14 9.18 7.85 8.00 
16 6.70 8.00 6.95 
22 6.30 8.00 7.30 
4 7.00 7.25 7.30 
7 6.48 6.90 7.30 
12 7.30 7.18 7.48 
5 7.30 8.78 7.60 
9 5.70 7.00 5.78 
15 6.90 5.70 7.60 
17 6.00 8.00 d? 
19 6.00 6.85 3.48 
24 7.70 8.43 8.30 
26 6.00 8.48 8.00 
d" indicates animal death 
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TABLE 3 SKIN GRAFT 
Bacterial Counts (log base 10) 
group 1 
group 2 
rat Day 5 Day 7 Day ' 
4 6.60 9.00 d 
5 7.74 8.85 9.00 
10 6.48 7.30 5.00 
15 5.48 4.60 7.00 
18 d d d 
26 7.30 8.30 d 
5 6.30 6.30 5.85 
6 7.00 6.60 5.60 
9 7.30 8.00 8.00 
3 6.78 5.90 4.00 
4 5.48 2.30 3.00 
7 6.78 6.00 3.48 
12 7.85 d d 
16 6.70 5.85 0 
21 5.30 3.00 6.00 
25 d d d 
d" indicates animal death 
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TABLE 4 GAUZE 
Bacterial Counts (log base 10) 
group 1 
group 2 
rat Day 5 Day 7 Day 1 
2 8.85 d d 
9 6.70 7.18 8.43 
13 6.78 7.70 7.70 
19 7.40 9.23 d 
21 7.30 8.00 3.00 
1 7.48 8.85 8.30 
8 3.00 3.00 3.00 
10 5.00 7.40 8.30 
13 6.48 6.78 7.85 
1 6.00 7.60 7.00 
2 5.80 7.30 8.43 
8 6.60 7.30 7.70 
10 6.00 7.30 8.00 
20 7.30 8.48 7.30 
27 6.60 d d 
28 d d d 
d" indicates animal death 
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Table 5 is a summary of the results. Log bacterial counts from 
wounds treated with fresh xenogeneic amniotic membrane or lyophilized 
xenogeneic amniotic membrane were not significantly different from each 
other or from the gauze contol group. Neither treatment decreased log 
bacterial counts. Fresh allogeneic full thickness skin graft 









Fresh AM 13 7.64 
Lyo. AM 15 7.63 
Skin Graft 12 6.64 
Control 12 7.76 
AM - amniotic membrane 
of Log Bacterial Counts 
Day 9 
sample 
SE size mean SE 
.27 11 7.92 0.31 
.25 13 7.49 0.29 
.23 9 5.99 0.34 









Previous investigations quantifying the antibacterial efficacy of 
fresh amniotic membrane have been few. No report has been sufficiently 
detailed to permit critical evaluation of the results. Anecdotal 
cinical reviews have suggested that fresh allogeneic amniotic membrane 
is able to "clean-up" a wound. Robson and Krizek have presented two 
points: 
1) fresh xenogeneic amniotic membrane is more effective than fresh split 
thickness xenogeneic skin in reducng bacterial counts in a septic burn 
wound model. 
2) Fresh xenogeneic amniotic membrane is more effective than either 
fresh allogeneic or xenogeneic split thickness skin and comparable to 
fresh autograft split thickness skin in reducing the bacterial counts in 
a septic non-thermal wound model. 
In this experiment, fresh xenogeneic amniotic membrane, lyophilized 
xenogeneic amniotic membrane, fresh full thickness allogeneic skin were 
evaluated. Treatment with either fresh or lypophilized xenogeneic 
amniotic was no better (and no worse) than the control regimen. 
Allogeneic full thickness skin however, significantly decreased the log 
bacterial count in the wound bed [by Day 9 an average of 2 (log) orders 
of magnitude]. The lack of antibacterial effect of fresh xenogeneic 
amniotic membrane in this study directly contradicts the findings of 
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Robson and Krizek. 
This was surprising inasmuch as a premise of this experiment (assumed 
but not required) was that fresh amniotic membrane is an effective 
antibacterial biologic dressing. The intent at the outset was to build 
on the previous investigations. Thus every attempt was made to 
duplicate the standard septic burn wound model used by Robson and Krizek 
in their fundamental investigation of the antibacterial efficacy of 
amniotic membrane. However an identical series of biologic dressings 
was not used. In the Robson and Krizek burn wound model xenograft skin 
was compared to xenograft amniotic membrane. Allogeneic skin was 
compared to xenogeneic amniotic membrane in a non-thermal v/ound. But in 
both these settings fresh amniotic membrane was an effective biologic 
dressing as measured by antibacterial activity. In this experiment no 
such efficacy was demonstrated. It is very important to keep in mind 
when considering this finding that allogeneic skin was very effective. 
In the current study the efficacy of allogeneic skin served to document 
the validity of the experimental model. 
The unexpected results of this study are consistant with the 
following hypothesis. That is, 1) the antibacterial efficacy of 
amniotic membrane is dependent on the occurance of "take" and 2) "take" 
only occurs when there exists allogeneity between the recipient and the 
graft donor. Xenogeneic amniotic membrane does not "take" and does not 
demonstrate antibacterial properties. 
Such an hypothesis explains why only allogeneic skin successfully 
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reduced the wound bed bacterial counts in this model. It suggests that 
for a true test of amniotic membrane as an antibacterial biologic 
dressing, one more closely simulating the clinical experience, 
allogeneic amniotic membrane should be used. This is an avenue which 
should be explored further before any conclusion about the antibacterial 
effectiveness of amniotic membrane is reached. 
Several questions were posed above (see Study Design) in regards to 
the importance of intrinsic antibacterial factors, viability of amniotic 
membrane, take, and genetic disparity. The participation of factors 
intrinsic to biologic dressings in general, in processes leading to the 
reduction of wound bed infection, is not supported by these results. In 
particular there is no evidence for them in amniotic membrane, and there 
are other more logical explanations for the success of the allogeneic 
skin graft. However their existence in amniotic membrane is not 
disproved. Certainly one can suggest reasons why they may function in 
other situations but did not in this model. Perhaps, in an allogeneic 
situation, as exists in the clinical treatment of burn wounds with human 
amniotic membrane, the membrane "takes", allowing integration of the 
intrinsic factors into the wound bed. Another possibility is that the 
factors are available only in small quantities and need to be 
replenished by dressing changes more frequently than done here. 
No answer can be given as to whether viability of the amniotic 
membrane is required for the activity of amniotic membrane intrinsic 
factors. Neither the lyophilized (non-viable) membrane nor the fresh 
(viable) membrane exhibiited antibacterial efficacy. 
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It is evident from the preeceeding discussion that the question of 
"take" of a biologic dressing is exceptionally important. "Take" is 
very hard to define, literally. Some investigators have attempted to 
measure "take" by adherence to the wound bed, others by observations of 
microscopic vascularity or gross appearence, and still others by the 
development of antibody to the biologic dressing in the temporary host. 
"Take" is therefore defined by its effects rather than a clear 
conception of what actually occurs. This too, is an avenue to be 




Fresh or lyophilized amniotic membrane is not effective in reducing the 
bacterial population of a xenogeneic septic burn wound model. No 
conclusions should be drawn from this work about the efficacy of 
amniotic membrane as a biologic dressing in the non-infected or clinical 
(allogeneic) wound. Allogeneic full-thickness skin has again proven to 
be an effective antibacterial biologic dressing. These findings are 
consistent with hypothesis that "take", which only occurs in allogeneic 
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